Home › Funds › Tejara Capital Ltd › CRDL

Tejara Capital Ltd position in CRDL

CARDIOL THERAPEUTICS INC · Health Care

Tejara Capital Ltd reported holding 7,420,429 shares of CRDL (CARDIOL THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.3M, representing 6.02% of its reported portfolio and ranking #5 among its reported holdings. Tejara Capital Ltd has disclosed CRDL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)7.42M sh
Reported value held$12.32M
Portfolio Weight6.02%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tejara Capital Ltd's CRDL position evolved

Tejara Capital Ltd first disclosed a stake in CRDL in Q3 2023 at 645,457 shares (US$578K). The position peaked in Q3 2026 at 7,420,429 shares, worth US$12.3M. Across 13 filings, Tejara Capital Ltd increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 7,420,429 shares valued at US$12.3M — an increase of 2,306,607 shares quarter over quarter.. Notable position changes include a 73% increase in Q4 2023 (shares rose 115% over the following quarter), a 76% increase in Q4 2024 (shares fell 24% over the following quarter), a 95% increase in Q4 2025 (shares rose 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 645.46K $577.68K New
Q4 2023 1.12M $941.58K Add
Q1 2024 1.64M $2.98M Add
Q2 2024 1.72M $3.48M Add
Q3 2024 1.77M $3.51M Add
Q4 2024 3.12M $3.99M Add
Q1 2025 3.19M $3.10M Add
Q2 2025 3.27M $4.44M Add
Q3 2025 2.63M $2.81M Reduce
Q4 2025 5.13M $4.89M Add
Q1 2026 5.13M $6.93M Hold
Q2 2026 5.11M $5.42M Hold
Q3 2026 7.42M $12.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRDL and 13F data

CRDL (CARDIOL THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CRDL — the largest reported positions include MMCAP International Inc. SPC (US$25.9M), AIGH Capital Management LLC (US$166K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRDL

All CRDL fund holders →

FAQ

How long has Tejara Capital Ltd held CRDL?

Tejara Capital Ltd has disclosed CRDL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Tejara Capital Ltd's current position in CRDL?

As of Q3 2026, Tejara Capital Ltd holds 7.42M shares of CRDL (CARDIOL THERAPEUTICS INC), valued at $12.32M, representing 6.02% of its reported portfolio and ranking #5.

Has Tejara Capital Ltd been buying or selling CRDL?

In the latest 13F filing (Q3 2026), Tejara Capital Ltd increased its position in CRDL. The position peaked in Q3 2026 at 7.42M shares.

Which other funds hold CRDL?

Other major institutional holders of CRDL include MMCAP International Inc. SPC, AIGH Capital Management LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.